Cite
A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators.
MLA
Robertsen, Ida, et al. “A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators.” Clinical Pharmacokinetics, vol. 57, no. 11, Nov. 2018, pp. 1459–69. EBSCOhost, https://doi.org/10.1007/s40262-018-0646-5.
APA
Robertsen, I., Debord, J., Åsberg, A., Marquet, P., & Woillard, J.-B. (2018). A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators. Clinical Pharmacokinetics, 57(11), 1459–1469. https://doi.org/10.1007/s40262-018-0646-5
Chicago
Robertsen, Ida, Jean Debord, Anders Åsberg, Pierre Marquet, and Jean-Baptiste Woillard. 2018. “A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators.” Clinical Pharmacokinetics 57 (11): 1459–69. doi:10.1007/s40262-018-0646-5.